LAURA HOLLENSWORTH: Open Payments
NPI 1578584900 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 94 payments from 26 companies in 2025. Trend: 2023 $1,642 · 2024 $1,659 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $278 |
| Novo Nordisk Inc | 17 | $235 |
| Axsome Therapeutics, Inc. | 7 | $115 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| PFIZER INC. | 5 | $94 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Exact Sciences Corporation | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
Products named: Ozempic, QULIPTA, REXULTI, UBRELVY, Wegovy, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across AL — which companies pay providers there.
